RIGL
#2443
Rigel Pharmaceuticals, Inc. - Common Stock
49.4 7 USD
+0.01%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+0.79%
Changement Mensuel
+4.54%
Evolution sur 6 mois
+70.53%
Changement Annuel
+64.19%
Clôture Précédente
49.0 8
Open
49.0 3
Low
49.0 3
High
49.8 9
Financials
- Market Capitalization 924.09 M
- Employee 174
- Founded 1996
- CEO N/A
- Website www.rigel.com
- Headquarter Delaware, United States
- FIGI BBG000BPWTW7
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
2.2
ratio cours/chiffre d'affaires
2.74
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2432 |  ALMS Alumis Inc. - Common Stock | 7.11 USD | -0.70% | +2.01% | -23.14% | +57.65% | 920.28 M USD | ||
| 2436 |  MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | 10.80 USD | -0.18% | -5.26% | -14.01% | +12.97% | 919.15 M USD | ||
| 2444 |  JBIO Jade Biosciences, Inc. - Common Stock | 14.39 USD | +1.70% | +1.70% | -20.32% | +43.18% | 915.17 M USD | ||
| 2470 |  CRVS Corvus Pharmaceuticals, Inc. - Common Stock | 10.46 USD | -0.57% | -1.97% | -19.04% | +42.70% | 879.91 M USD |